Study Evaluating the Efficacy and Safety With CAR-T for Liver Cancer

NCT02729493 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Neoplasms

Interventions

BIOLOGICAL: EPCAM-targeted CAR-T cells

Sponsor

Sinobioway Cell Therapy Co., Ltd.